Studies on yeast nucleoside triphosphate-nucleoside diphosphate transphosphorylase (nucleoside diphosphokinase). IV. Steady-state kinetic properties with thymidine nucleotides (including 3'-azido-3'-deoxythymidine analogues). 1991

S A Kuby, and G Fleming, and T Alber, and D Richardson, and H Takenaka, and M Hamada
Department of Biochemistry, University of Utah, Salt Lake City.

A study of the steady-state kinetics of the crystalline brewer's yeast (Saccharomyces carlsbergensis) nucleoside diphosphokinase, with the magnesium complexes of the adenine and thymidine nucleotides as reactants, has led to a postulated kinetic mechanism which proceeds through a substituted enzyme. This agrees with the earlier conclusions of Garces and Cleland [Biochemistry 1969; 8:633-640] who characterized a reaction between the magnesium complexes of the adenine and uridine nucleotides. An advantage of using thymidine nucleotides as reactants is that they permit accurate, rapid and continuous assays of the enzymatic activity in coupled-enzymatic tests. Through measurements of the initial velocities and product inhibition studies, the Michaelis constants, maximum velocities, and inhibition constants could be evaluated for the individual substrates. Competitive substrate inhibition was encountered at relatively high substrate concentrations, which also permitted an evaluation of their ability to act as 'dead-end' inhibitors. The Michaelis constants for the 3'-azido-3'-deoxythymidine (AzT) analogues were also evaluated and, although these values were only somewhat higher than those of their natural substrates, the Km's for the adenine nucleotides as paired substrates were lower and the Vmax's were drastically reduced. The pharmacological implications of these observations are touched upon and extrapolated to the cases where therapeutic doses of AzT may be employed.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D010770 Phosphotransferases A rather large group of enzymes comprising not only those transferring phosphate but also diphosphate, nucleotidyl residues, and others. These have also been subdivided according to the acceptor group. (From Enzyme Nomenclature, 1992) EC 2.7. Kinases,Phosphotransferase,Phosphotransferases, ATP,Transphosphorylase,Transphosphorylases,Kinase,ATP Phosphotransferases
D000227 Adenine Nucleotides Adenine Nucleotide,Adenosine Phosphate,Adenosine Phosphates,Nucleotide, Adenine,Nucleotides, Adenine,Phosphate, Adenosine,Phosphates, Adenosine
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D012440 Saccharomyces A genus of ascomycetous fungi of the family Saccharomycetaceae, order SACCHAROMYCETALES. Saccharomyce
D013942 Thymine Nucleotides Phosphate esters of THYMIDINE in N-glycosidic linkage with ribose or deoxyribose, as occurs in nucleic acids. (From Dorland, 28th ed, p1154) Thymidine Phosphates,Nucleotides, Thymine,Phosphates, Thymidine
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U

Related Publications

S A Kuby, and G Fleming, and T Alber, and D Richardson, and H Takenaka, and M Hamada
September 1967, Biochemistry,
S A Kuby, and G Fleming, and T Alber, and D Richardson, and H Takenaka, and M Hamada
June 1973, The Journal of biological chemistry,
S A Kuby, and G Fleming, and T Alber, and D Richardson, and H Takenaka, and M Hamada
January 1964, The Journal of biological chemistry,
S A Kuby, and G Fleming, and T Alber, and D Richardson, and H Takenaka, and M Hamada
January 1989, Advances in experimental medicine and biology,
S A Kuby, and G Fleming, and T Alber, and D Richardson, and H Takenaka, and M Hamada
February 1969, Biochemistry,
S A Kuby, and G Fleming, and T Alber, and D Richardson, and H Takenaka, and M Hamada
February 1999, FEBS letters,
S A Kuby, and G Fleming, and T Alber, and D Richardson, and H Takenaka, and M Hamada
November 1990, The Journal of biological chemistry,
S A Kuby, and G Fleming, and T Alber, and D Richardson, and H Takenaka, and M Hamada
May 1998, The Journal of biological chemistry,
S A Kuby, and G Fleming, and T Alber, and D Richardson, and H Takenaka, and M Hamada
January 1989, Journal of medicinal chemistry,
S A Kuby, and G Fleming, and T Alber, and D Richardson, and H Takenaka, and M Hamada
July 1970, The Journal of biological chemistry,
Copied contents to your clipboard!